Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: atorvastatin calcium

« Back to Dashboard

Atorvastatin calcium is the generic ingredient in three branded drugs marketed by Apotex Inc, Dr Reddys Labs Ltd, Kudco Ireland, Mylan Pharms Inc, Ranbaxy Labs Ltd, Sandoz Inc, Teva Pharms, Pfizer, and Merck Sharp Dohme, and is included in ten NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifty-seven drug master file entries for atorvastatin calcium. Seventeen suppliers are listed for this compound.

Summary for Generic Name: atorvastatin calcium

Tradenames:3
Patents:5
Applicants:9
NDAs:10
Drug Master File Entries: see list57
Suppliers: see list17
Therapeutic Class:Cardiovascular Agents

Pharmacology for Ingredient: atorvastatin calcium

Clinical Trials for: atorvastatin calcium

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers
Status: Recruiting Condition: Healthy

Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia
Status: Completed Condition: Hypertriglyceridemia

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy Labs Ltd
ATORVASTATIN CALCIUM
atorvastatin calcium
TABLET;ORAL076477Nov 30, 2011RXNo<disabled><disabled>
Merck Sharp Dohme
LIPTRUZET
atorvastatin calcium; ezetimibe
TABLET;ORAL200153May 3, 2013RXNoRE42461*PED<disabled><disabled>
Merck Sharp Dohme
LIPTRUZET
atorvastatin calcium; ezetimibe
TABLET;ORAL200153May 3, 2013RXYesRE42461*PED<disabled><disabled>
Merck Sharp Dohme
LIPTRUZET
atorvastatin calcium; ezetimibe
TABLET;ORAL200153May 3, 2013RXNo5,846,966*PED<disabled>Y<disabled>
Pfizer
LIPITOR
atorvastatin calcium
TABLET;ORAL020702Dec 17, 1996RXNo5,686,104*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc